Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-070147

Options or other derivatives

  • Chief Scientific Officer acquired 42,210 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SMIDER VAUGHN · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +42,210 42,210 D
Loading xslF345X03/form471645_20141120045835-.xml…